Aprea Therapeutics Inc (APRE)

3.37 0.00 (0.00%) USD  |  NASDAQ  |  Dec 27, 16:00
3.46 +0.09 (+2.67%) After-Hours: 20:00
More

Aprea Therapeutics Enterprise Value: -7.934M for Dec. 27, 2024

Enterprise Value Chart

View Enterprise Value for APRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Enterprise Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
NovaBay Pharmaceuticals Inc 2.098M
Palatin Technologies Inc 19.31M
iBio Inc 12.31M
Theriva Biologics Inc -12.16M
Oragenics Inc 4.506M

Enterprise Value Related Metrics

Net Income (Quarterly) -3.784M
Total Expenses (Quarterly) 4.097M
EPS Diluted (Quarterly) -0.64
Earnings Yield -83.38%